IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management VI LLC

Portfolio Profile

CIK: 0002013341 | WEST HOLLYWOOD, CA

Investment Profile

Style

Deep Value

Turnover

Medium

Orientation

Concentrated trader
$642.6M
AUM
23
Positions
81.55%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1CG Oncology, Inc.(CGON)2,369,574$168.4M26.20%
2Alumis Inc.(ALMS)4,247,670$119.5M18.60%
3Seaport Therapeutics, Inc.(SPTX)1,779,521$38.7M6.01%
4Denali Therapeutics Inc.(DNLI)1,396,771$35.9M5.59%
5Celldex Therapeutics, Inc.(CLDX)879,713$32.7M5.09%

Sector Allocation

Latest filing, equity positions only

Healthcare84.75% · $544.6M
Unclassified15.25% · $98.0M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare98.45%84.75%-13.7%
Unclassified1.55%15.25%+13.7%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$224.4M | 14 pos.
$182.5M | 14 pos.
$177.9M | 20 pos.
$258.9M | 12 pos.
$330.8M | 12 pos.
$460.3M | 17 pos.
6
Agios Pharmaceuticals, Inc.(AGIO)
785,000
$29.1M
4.53%
7Corvus Pharmaceuticals, Inc.(CRVS)1,831,233$27.4M4.26%
8Parabilis Medicines, Inc.(PBLS)999,044$27.3M4.26%
9GH Research PLC(GHRS)940,493$25.3M3.93%
10Jade Biosciences, Inc.(JBIO)886,667$19.7M3.07%
Cap SizePrev %Curr %Change
Mid Cap78.1%61.11%-16.99%
Small Cap19.06%23.64%+4.58%
Unclassified1.55%15.25%+13.7%
Micro Cap1.3%0%-1.3%
$642.6M | 23 pos.
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

8
New
2
Closed
6
Increased
1
Decreased
8
Unchanged